University of British Columbia at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

University of British Columbia brings 3 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program includes an oral amphotericin B formulation for visceral leishmaniasis and explainable AI for drug development and medication safety. It also joins a discussion of global health careers for pharmaceutical scientists.

OrganizationAAPS 2026 PharmSci 360 Attendance
Talk
Mon Oct 26
12:00pm–1:00pm
From Passion to Practice: Global Health Opportunities for Pharmaceutical Scientists
Careers 360, Exhibit Hall
Career Development · with Serán Bioscience, Purdue University, Merck & Co.
Talk
Tue Oct 27
12:30pm–1:30pm
Explainable Artificial Intelligence in Pharmaceutical Development and Prescription Medication Safety: Past, Present and Future
360 Stage #4, Exhibit Hall
Preclinical, Clinical, and Translational Sciences · with Louisiana State University, Humanitas Global Health
Talk
Wed Oct 28
3:00pm–3:15pm
Part of Rapid Fire: Product Development with Patient in Mind
A Novel Oral Amphotericin B Formulation to Treat Visceral Leishmaniasis
220-222
Formulation and Delivery

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of British Columbia

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction